title: [Treatment of acute renal insufficiency using prostaglandin E2 in surgical patients].
abstract: The results of treatment with prostaglandin E2 (PgE2) of 26 surgical patients with acute renal failure (ARF) are presented. PgE2 at a daily dose of 1-1.5 mg was administered intravenously drop-by-drop for 3-7 days. Duration of therapy with PgE2 was defined by the degree of restoration of renal function and normalization of metabolic indices.
authors.forename: R M
authors.initials: RM
authors.lastname: Glants
authors.forename: V L
authors.initials: VL
authors.lastname: Turchin
authors.forename: V V
authors.initials: VV
authors.lastname: Chaplik
authors.forename: Iu Ia
authors.initials: IuIa
authors.lastname: Gribovich
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology; D015232:Dinoprostone / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D015232:Dinoprostone
vernacular_title: Lechenie ostroĭ pochechnoĭ nedostatochnosti prostaglandinom E2 u khirurgicheskikh bol'nykh.